Virtual Kidney Check and Follow-up
Launched by UNIVERSITY OF MANITOBA · Jan 15, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age\>= 18 years
- • Resident of Manitoba
- • First Nations
- • Urban, rural or remote location
- Exclusion Criteria:
- • Kidney failure (dialysis or transplant)
- • chronic kidney disease (estimated Glomerular Filtration Rate \<60 milliliter/1.73square meter for 3 months)
- • Screening for chronic kidney disease with estimated Glomerular Filtration Rate or Albumin to Creatinine ratio in the last 2 years
About University Of Manitoba
The University of Manitoba, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and community engagement to conduct rigorous and ethical clinical studies. The institution aims to translate scientific findings into practical applications that enhance patient care and improve health outcomes. Committed to fostering a culture of excellence and integrity, the University of Manitoba prioritizes participant safety and scientific validity in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winnipeg, , Canada
Patients applied
Trial Officials
David Collister, MD, PhD, FRCPC
Principal Investigator
University of Manitoba
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported